U.S. COMPRESSION THERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

The U.S. compression therapy market is estimated to be valued at USD 1,629.2 Mn in 2026 and is expected to reach USD 2,685.4 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033. The U.S. compression therapy market is a major segment of the medical devices industry, including products like compression stockings, bandages, bandages, pneumatic compression devices, and gradient compression clothing, designed to enhance blood circulation, reduce swelling, and treat chronic venous and lymphatic problems. They play a vital role in management of many medical problems like chronic venous insufficiency (CVI), deep vein thrombosis (DVT), lymphedema and peripheral artery disease and enable preventive and rehabilitative care to various patient groups.

The growth of the U.S. compression therapy market is attributed to the increasing prevalence of vascular disorders, rising geriatric population, increasing obesity prevalence, and rising number of surgical procedures requiring post-operative compression therapy. Comfort level of patients and compliance to treatment have been improved by the continuous advancements in material science and wearable medical technologies. The established healthcare infrastructure, favorable reimbursement environment, and rising awareness among healthcare professionals and patients in the country continue to support the widespread use of compression therapy solutions.

Market Dynamics

U.S. compression therapy market is primarily driven by the rising prevalence of chronic venous insufficiency (CVI), lymphedema, deep vein thrombosis (DVT), obesity, diabetes and other circulatory disorders that require long-term compression management. Factors such as an aging population, a growing number of orthopedic and cardiovascular surgeries, and a higher acceptance of compression therapy for post-operative recovery are also driving the market. Also, advances in pneumatic compression systems, smart compression garments and wearable technologies have enhanced the clinical applications in the hospital and home-care settings.

However, the growth of market is limited by factors such as high cost of advanced compression devices, inconsistent reimbursement policies, and patient non-compliance due to discomfort or improper use. Nevertheless, there are abundant growth prospects due to factors such as rising demand for home healthcare, the shift to outpatient care, and the adoption of digital health technologies such as telehealth-enabled and connected compression devices.

Key Features of the Study

• This report provides in-depth analysis of the U.S. compression therapy market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the U.S. compression therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Cardinal Health, 3M, SIGVARIS GROUP, Essity, Julius Zorn, Inc., HARTMANN USA, Inc., Bauerfeind USA Inc., medi USA, BIOCOMPRESSION SYSTEMS, and Gottfried Medical, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The U.S. compression therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the U.S. compression therapy market

Market Segmentation

• Technology Insights (Revenue, USD Mn, 2021 - 2033)
  • Static Compression Therapy
  • Dynamic Compression Therapy
• Product Type Insights (Revenue, USD Mn, 2021 - 2033)
  • Compression Garments
  • Compression Stockings
  • Compression Bandages
  • Compression Tapes
  • Compression Pumps
• Application Insights (Revenue, USD Mn, 2021 - 2033)
  • Varicose Vein
  • Deep Vein Thrombosis
  • Lymphedema
  • Leg Ulcer
• Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
  • Pharmacies
  • E-commerce
  • Others
• Key Players Insights
  • Cardinal Health
  • 3M
  • SIGVARIS GROUP
  • Essity
  • Julius Zorn, Inc.
  • HARTMANN USA, Inc.
  • Bauerfeind USA Inc.
  • medi USA
  • BIOCOMPRESSION SYSTEMS
  • Gottfried Medical, Inc.